Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141

BAL9141, a new antimicrobial agent belonging to the class of parenteral pyrrolidinone-3-ylidenemethyl cephalosporins, is active against most gram-positive microorganisms, including methicillin-resistant variants (methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-resistant Staphyloco...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Mouton, Johan W., Schmitt-Hoffmann, Anne, Shapiro, Stuart, Nashed, Norman, Punt, Nieko C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2004
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400534/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105125/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1713-1718.2004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi